Placebo for CBP-0276

DRUG2 trials

Sponsors

Clarent Biopharma, Inc.

Conditions

Hip or Knee ReplacementPsoriasis

Phase 2

Safety and Efficacy of CBP-0276 to Improve Severity and Quality of Life on Moderate to Severe Psoriasis in Subjects

RecruitingNCT07204639

Clarent Biopharma, Inc.Psoriasis

Start: 2025-10-01End: 2026-08-30Target: 100Updated: 2026-06-30

CBP-0276 to Reduce Opioid Use in Adults Undergoing Major Orthopedic Surgery

RecruitingNCT07687966

Clarent Biopharma, Inc.Hip or Knee Replacement

Start: 2026-05-08End: 2026-09-30Target: 80Updated: 2026-07-07